About
About Avecho
Board & Leadership
TPM
®
Technology
Portfolio
Pipeline
Cannabinoids
Pharmaceutical
Animal Health
Manufacturing
Invest
Investor Centre
Media Centre
Contact
Hit enter to search or ESC to close
Phosphagenics and Mylan Agree Settlement
December 19, 2018
Click here to read more
Post navigation
Previous Post
Voluntary Withdrawal from OTCQX
Next Post
2019 Annual General Meeting Results
Related Posts
Results for Phase I human clinical trial of CBD soft-gel product
December 8, 2021
December 8, 2021
Mylan Arbitration Update – expert report on quantum of damages claimed filed
May 29, 2017
Avecho licenses TPM® for development of enhanced cancer drugs
May 22, 2023
May 22, 2023